News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
650,835 Results
Type
Article (33669)
Company Profile (640)
Press Release (616526)
Multimedia
Podcasts (53)
Webinars (11)
Section
Business (197031)
Career Advice (2101)
Deals (36182)
Drug Delivery (102)
Drug Development (77542)
Employer Resources (163)
FDA (15428)
Job Trends (14696)
News (332172)
Policy (28856)
Tag
Academia (1344)
Academic (1)
Accelerated approval (5)
Adcomms (13)
Allergies (84)
Alliances (46808)
ALS (94)
Alzheimer's disease (1300)
Antibody-drug conjugate (ADC) (137)
Approvals (15419)
Artificial intelligence (248)
Autoimmune disease (28)
Automation (13)
Bankruptcy (376)
Best Places to Work (10903)
BIOSECURE Act (22)
Biosimilars (97)
Biotechnology (437)
Bladder cancer (77)
Brain cancer (24)
Breast cancer (246)
Cancer (2100)
Cardiovascular disease (168)
Career advice (1733)
Career pathing (32)
CAR-T (149)
Cell therapy (428)
Cervical cancer (17)
Clinical research (63598)
Collaboration (840)
Company closure (1)
Compensation (531)
Complete response letters (27)
COVID-19 (2178)
CRISPR (42)
C-suite (259)
Cystic fibrosis (98)
Data (2115)
Decentralized trials (2)
Denatured (3)
Depression (50)
Diabetes (253)
Diagnostics (6302)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (112)
Drug pricing (101)
Drug shortages (24)
Duchenne muscular dystrophy (88)
Earnings (83099)
Editorial (37)
Employer branding (24)
Employer resources (139)
Events (109550)
Executive appointments (743)
FDA (16615)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (739)
Gene editing (109)
Generative AI (24)
Gene therapy (305)
GLP-1 (719)
Government (2907)
Grass and pollen (6)
Guidances (59)
Healthcare (16197)
Huntington's disease (23)
IgA nephropathy (29)
Immunology and inflammation (127)
Indications (29)
Infectious disease (2313)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (98)
Interviews (424)
IPO (17198)
IRA (41)
Job creations (4221)
Job search strategy (1436)
Kidney cancer (10)
Labor market (36)
Layoffs (540)
Leadership (19)
Legal (7201)
Liver cancer (70)
Lung cancer (296)
Lymphoma (137)
Machine learning (4)
Management (58)
Manufacturing (322)
MASH (67)
Medical device (13691)
Medtech (13696)
Mergers & acquisitions (19533)
Metabolic disorders (673)
Multiple sclerosis (81)
NASH (18)
Neurodegenerative disease (99)
Neuropsychiatric disorders (31)
Neuroscience (1854)
NextGen: Class of 2025 (6007)
Non-profit (1929)
Now hiring (40)
Obesity (362)
Opinion (247)
Ovarian cancer (69)
Pain (93)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (19)
Patents (237)
Patient recruitment (111)
Peanut (48)
People (56806)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20054)
Phase II (28431)
Phase III (21019)
Pipeline (1213)
Policy (136)
Postmarket research (1910)
Preclinical (8090)
Press Release (64)
Prostate cancer (102)
Psychedelics (35)
Radiopharmaceuticals (260)
Rare diseases (374)
Real estate (5712)
Recruiting (64)
Regulatory (20696)
Reports (35)
Research institute (1333)
Resumes & cover letters (330)
Rett syndrome (4)
RNA editing (5)
RSV (43)
Schizophrenia (77)
Series A (136)
Series B (90)
Service/supplier (26)
Sickle cell disease (51)
Special edition (16)
Spinal muscular atrophy (145)
Sponsored (21)
Startups (3882)
State (2)
Stomach cancer (12)
Supply chain (70)
Tariffs (43)
The Weekly (49)
Vaccines (652)
Venture capitalists (44)
Weight loss (244)
Women's health (24)
Worklife (19)
Date
Last 7 days (895)
Last 30 days (2466)
Last 365 days (32837)
2025 (10778)
2024 (35571)
2023 (40341)
2022 (50585)
2021 (53789)
2020 (50825)
2019 (42057)
2018 (32149)
2017 (32537)
2016 (30799)
2015 (36161)
2014 (28911)
2013 (23925)
2012 (25503)
2011 (25642)
2010 (23515)
Location
Africa (665)
Alabama (59)
Alaska (6)
Arizona (171)
Arkansas (11)
Asia (40059)
Australia (6562)
California (6202)
Canada (2000)
China (531)
Colorado (267)
Connecticut (281)
Delaware (144)
Europe (87552)
Florida (874)
Georgia (204)
Hawaii (1)
Idaho (55)
Illinois (468)
India (28)
Indiana (318)
Iowa (12)
Japan (156)
Kansas (100)
Kentucky (24)
Louisiana (11)
Maine (65)
Maryland (777)
Massachusetts (4765)
Michigan (235)
Minnesota (396)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (22)
Nevada (59)
New Hampshire (66)
New Jersey (1739)
New Mexico (30)
New York (1725)
North Carolina (1059)
North Dakota (7)
Northern California (2686)
Ohio (190)
Oklahoma (10)
Oregon (40)
Pennsylvania (1345)
Puerto Rico (12)
Rhode Island (35)
South America (1064)
South Carolina (22)
South Dakota (1)
Southern California (2263)
Tennessee (82)
Texas (892)
United States (23114)
Utah (179)
Virginia (145)
Washington D.C. (58)
Washington State (572)
West Virginia (3)
Wisconsin (52)
650,835 Results for "orthopaedic implant company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Zeda Announces Acquisition of The Orthopaedic Implant Company
Zeda, Inc. (Zeda), a global leader in innovative healthcare solutions, proudly announced today the acquisition of The Orthopaedic Implant Company (OIC), an orthopaedic implant company recognized as the leader in value-based implants.
February 13, 2024
·
2 min read
Pharm Country
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that the U.S. Food & Drug Administration (FDA) granted the company a De Novo approval for its novel antibacterial coated implants.
April 8, 2024
·
4 min read
Press Releases
Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025
March 11, 2025
·
14 min read
Press Releases
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
March 12, 2025
·
3 min read
Press Releases
Envoy Medical Reports on First Quarter 2025 Results
Company Provides Update on Its Pivotal Clinical Study for Fully Implanted Cochlear Implant
May 1, 2025
·
13 min read
Genetown
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
Hyalex Orthopaedics today announced that patients have successfully received HYALEX Knee Implants as part of the company’s first-in-human clinical trials of its novel HYALEX Knee Cartilage System.
April 22, 2024
·
3 min read
Press Releases
Dr. Samuel A. Joseph Jr. Named Clinical Assistant Professor of Orthopaedic Surgery at HCA/USF Orthopaedic Program
February 26, 2025
·
1 min read
Genetown
Miach Orthopaedics Raises $20 Million in Series B Extension
Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration Implant, announced closing of a $20 million Series B extension financing round.
April 2, 2024
·
4 min read
Press Releases
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
May 1, 2025
·
4 min read
Press Releases
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
February 24, 2025
·
7 min read
1 of 65,084
Next
